126 related articles for article (PubMed ID: 2569220)
1. Expression of the c-erbB-2 proto-oncogene protein in human breast cancer.
Gullick WJ
Recent Results Cancer Res; 1989; 113():51-6. PubMed ID: 2569220
[TBL] [Abstract][Full Text] [Related]
2. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.
Yokota J; Yamamoto T; Toyoshima K; Terada M; Sugimura T; Battifora H; Cline MJ
Lancet; 1986 Apr; 1(8484):765-7. PubMed ID: 2870269
[TBL] [Abstract][Full Text] [Related]
3. Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.
Børresen AL; Ottestad L; Gaustad A; Andersen TI; Heikkilä R; Jahnsen T; Tveit KM; Nesland JM
Br J Cancer; 1990 Oct; 62(4):585-90. PubMed ID: 1977466
[TBL] [Abstract][Full Text] [Related]
4. [Proto-oncogene C-erbB-2 and human cancer].
Toyoshima K
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):309-14. PubMed ID: 1968737
[TBL] [Abstract][Full Text] [Related]
5. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
[TBL] [Abstract][Full Text] [Related]
6. c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.
Tavassoli M; Quirke P; Farzaneh F; Lock NJ; Mayne LV; Kirkham N
Br J Cancer; 1989 Oct; 60(4):505-10. PubMed ID: 2572268
[TBL] [Abstract][Full Text] [Related]
7. NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue.
Corbett IP; Henry JA; Angus B; Watchorn CJ; Wilkinson L; Hennessy C; Gullick WJ; Tuzi NL; May FE; Westley BR
J Pathol; 1990 May; 161(1):15-25. PubMed ID: 1973458
[TBL] [Abstract][Full Text] [Related]
8. Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy.
Hynes NE
Semin Cancer Biol; 1993 Feb; 4(1):19-26. PubMed ID: 8095411
[TBL] [Abstract][Full Text] [Related]
9. Expression of growth factor receptors in human brain tumours.
Tuzi NL; Venter DJ; Kumar S; Staddon SL; Lemoine NR; Gullick WJ
Br J Cancer; 1991 Feb; 63(2):227-33. PubMed ID: 1671751
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification.
Venter DJ; Tuzi NL; Kumar S; Gullick WJ
Lancet; 1987 Jul; 2(8550):69-72. PubMed ID: 2885574
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors.
Nagai MA; Marques LA; Torloni H; Brentani MM
Oncology; 1993; 50(6):412-7. PubMed ID: 7901824
[TBL] [Abstract][Full Text] [Related]
12. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.
Berger MS; Locher GW; Saurer S; Gullick WJ; Waterfield MD; Groner B; Hynes NE
Cancer Res; 1988 Mar; 48(5):1238-43. PubMed ID: 2893663
[TBL] [Abstract][Full Text] [Related]
13. [The significance of c-erbB-2 and int-2 gene alterations and DNA ploidy pattern for aggressiveness of breast cancer].
Nagayama K; Watatani M; Maeda S; Imanishi Y; Kurooka K; Wada T; Yasutomi M
Nihon Geka Gakkai Zasshi; 1993 Oct; 94(10):1144-52. PubMed ID: 7901748
[TBL] [Abstract][Full Text] [Related]
14. ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer.
Borg A; Baldetorp B; Fernö M; Killander D; Olsson H; Rydén S; Sigurdsson H
Cancer Lett; 1994 Jun; 81(2):137-44. PubMed ID: 7912163
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.
Singleton TP; Strickler JG
Pathol Annu; 1992; 27 Pt 1():165-90. PubMed ID: 1346551
[TBL] [Abstract][Full Text] [Related]
16. c-erbB-2 proto-oncogene expression and its relationship to survival in gastric carcinoma: an immunohistochemical study on archival material.
Jain S; Filipe MI; Gullick WJ; Linehan J; Morris RW
Int J Cancer; 1991 Jul; 48(5):668-71. PubMed ID: 1676988
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer.
Horak E; Smith K; Bromley L; LeJeune S; Greenall M; Lane D; Harris AL
Oncogene; 1991 Dec; 6(12):2277-84. PubMed ID: 1685017
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous expression of erbB-2 messenger RNA in human breast cancer.
King CR; Swain SM; Porter L; Steinberg SM; Lippman ME; Gelmann EP
Cancer Res; 1989 Aug; 49(15):4185-91. PubMed ID: 2568168
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer.
Gusterson BA; Machin LG; Gullick WJ; Gibbs NM; Powles TJ; Price P; McKinna A; Harrison S
Int J Cancer; 1988 Dec; 42(6):842-5. PubMed ID: 2903851
[TBL] [Abstract][Full Text] [Related]
20. [Amplification and expression of oncogenes in human malignant tumors--organ or tissue specificity and prognosis].
Ueda M; Shimizu N; Abe O
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1579-81. PubMed ID: 2573817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
